From mood trackers to guided cognitive-behavioral therapy (CBT) and peer support, depression apps are crowding the digital marketplace. As more patients turn to this technology to ease their symptoms, ...

SALT LAKE CITY, Sept. 3, 2025 – Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced the publication of a new meta-analysis of six ...

A new genetic and clinical analysis suggests that atypical depression represents a distinct biological subtype of the ...

An experimental depression drug that joined the Neurocrine Biosciences pipeline as part of a broader package from Takeda Pharmaceutical failed to meet the main goal of a mid-stage clinical trial. The ...

When we think about where psychological disorders come from, we often hear about genetic evolution. This usually leads to explanations that focus on inherited biological factors. But for many human ...

Patients with major depressive disorder, including those who have not responded to first-line antidepressants, may benefit from short-term nitrous oxide treatment, a major meta-analysis led by the ...